Senvest Management
VC Fund
New York, United States
Senvest Management is a privately owned hedge fund sponsor. The firm invests in the public equity markets of the United States. It primarily invests value and growth stocks of small-cap and mid-cap companies. The firm employs a contrarian stock picking approach. It typically invests in technology, financial services, industrial, and resourcescompanies. Senvest Management is based in New York City.
- Total investments:
- 13
- Last investment:
- Lead investor:
- 8%
Last updated:
For AI agents: llms.txt
Industries Senvest Management invests in
Stages Senvest Management invests in
Countries Senvest Management invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Bobby Trahanas
|
|||
Brian Gonick
|
|||
Jim Turkenkopf
|
|||
|
Joy Mashaal
|
|||
|
Richard Mashaal
|
Investment Focus
Industry
- Manufacturing 3 (23%)
- Medical 2 (15%)
- Health Care 2 (15%)
- Biotechnology 2 (15%)
- Medical Device 2 (15%)
Stage
- Series B 4 (31%)
- Post-IPO Equity 4 (31%)
- Venture - Series Unknown 2 (15%)
- Series D 1 (8%)
- Funding Round 1 (8%)
Country
- United States 10 (77%)
- Israel 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Bobby Trahanas
Chief Compliance Officer
|
Chief Compliance Officer | Total investments: 0 | Find email | |
|
Brian Gonick
Co-Chief Investment Officer
|
Co-Chief Investment Officer | Total investments: 1 | Find email | |
|
Jim Turkenkopf
Head Trader
|
Head Trader | Total investments: 0 | Find email | |
|
Joy Mashaal
Managing Director
|
Managing Director | Total investments: 1 | Find email | |
|
Richard Mashaal
Founder
|
Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Jupiter Endovascular
|
Jupiter Endovascular is a medical technology startup developing the endoportal procedure, a new class of endovascular procedures using Endoportal Control to bring the precision and control of direct surgical access to catheter-based interventions. The procedure uses an endoportal device that navigates flexibly through the vasculature viapercutaneous access. Once in position, the endoportal device can be fixed into a stable state to deliver an interventional treatment with surgical-like precision and control from an endovascular access point. | Series B / Oct 07, 2025 | |
Biolinq
|
Biolinq is a digital health platform developer that aims to create a pipeline of biomonitoring solutions. The company's platform includes a skin-applied, minimally invasive electrochemical biosensor that analyzes biomarkers in the interstitial fluid to provide actionable health information while continuously monitoring multiple biomarkers,allowing diabetic patients to monitor their blood glucose levels. | $58M / Venture - Series Unknown / Apr 04, 2024 | |
|
Biolinq
|
Biolinq is a digital health platform developer that aims to create a pipeline of biomonitoring solutions. The company's platform includes a skin-applied, minimally invasive electrochemical biosensor that analyzes biomarkers in the interstitial fluid to provide actionable health information while continuously monitoring multiple biomarkers,allowing diabetic patients to monitor their blood glucose levels. | $58M / Series D / Apr 04, 2024 | |
iAnthus
|
iAnthus provides financial operations to manage the cannabis industry. They focus on providing insights and solutions to cultivate and produce cannabis-based products for medical purposes. | $14M / Post-IPO Debt / Feb 02, 2023 | |
Watt Fuel Cell
|
WATT Fuel Cell Corporation is a developer and manufacturer of Solid Oxide Fuel Cell (SOFC) components and systems that can operate on readily available hydrocarbon fuels such as natural gas, propane, JP-8, and diesel. WATT’s fuel cell technology is a quiet, light, efficient, affordable, and environmentally responsible energy solution to a range ofpower markets. The company's products are based on a common expandable module, a building block that enables WATT to address multiple markets with minimal additional development cost. Analogous to a blade server type module, where additional performance can be obtained by adding blades, applications requiring more power are addressed by simply adding more modules. | Venture - Series Unknown / Feb 23, 2022 | |
Tasso
|
Tasso is revolutionizing blood-based diagnostics by placing the user at the center of the diagnostics process. Patients are able to sample their own blood in the comfort of their home with a device that is safe, simple, and convenient. | $100M / Series B / Dec 16, 2021 | |
|
Biolinq
|
Biolinq is a digital health platform developer that aims to create a pipeline of biomonitoring solutions. The company's platform includes a skin-applied, minimally invasive electrochemical biosensor that analyzes biomarkers in the interstitial fluid to provide actionable health information while continuously monitoring multiple biomarkers,allowing diabetic patients to monitor their blood glucose levels. | $100M / Series B / Nov 02, 2021 | |
Redwire
|
Redwire is uniquely positioned to assist its customers in solving the complex challenges of future space missions. | $100M / Post-IPO Equity / Sep 03, 2021 | |
Otonomo
|
Otonomo fuels a data ecosystem of OEMs, fleets, and more than 100 service providers. Our platform securely ingests more than 4 billion data points per day globally from over 40 million vehicles licensed on the platform, then reshapes and enriches it, to accelerate time to market for new services that improve the in-and-around the car experience.Privacy by design and neutrality are at the core of our platform, which enables GDPR, CCPA, and other privacy-regulation-compliant solutions using both personal and aggregate data. Use cases include emergency services, mapping, EV management, subscription-based services, parking, predictive maintenance, insurance, media, in-vehicle services, traffic management, and smart city solutions. | $172.5M / Post-IPO Equity / Aug 16, 2021 | |
Rockley Photonics
|
Rockley is developing a comprehensive range of photonic integrated circuits and associated modules, sensors, and full-stack solutions. From next-generation sensing platforms specifically designed for mobile health monitoring and machine vision to high-speed, high-volume solutions for data communications, Rockley is laying the foundation for a newgeneration of applications across multiple industries. Rockley believes that photonics will eventually become as pervasive as micro-electronics, and it has developed a platform with the power and flexibility needed to address both mass markets and a wide variety of vertical applications. | $150M / Post-IPO Equity / Aug 12, 2021 | |
| See all 13 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Senvest Management invest in?
Senvest Management invests primarily in Manufacturing, Medical and Health Care startups, most often at Series B and Post-IPO Equity stage. Most of the 13 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Senvest Management?
Public channels for Senvest Management include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Senvest Management?
The team at Senvest Management includes Bobby Trahanas (Chief Compliance Officer), Brian Gonick (Co-Chief Investment Officer) and Jim Turkenkopf (Head Trader). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
